“C” to Believe: Jefferson Scientists Studying the Effects of High Dose Vitamin C on Non-Hodgkin Lymphoma Patients
(Published 1-2-2008) Scientists at Thomas Jefferson University Hospital and Jefferson’s Kimmel Cancer Center have received approval for a first-of-its kind study on the effect high dose vitamin C has on non-Hodgkin lymphoma patients. Researchers from the Jefferson-Myrna Brind Center of Integrative Medicine and Kimmel Cancer Center in conjunction with the National Institutes of Health will study whether high doses of vitamin C can slow the progression of the deadly disease.

Hitting the Slopes this Season? Beware of a Little Known Orthopaedic Health Hazard
(Published 1-10-2008) Most likely you’ve never heard of the term “skier’s thumb” -- unless you’re one of the unlucky snow bunnies, weekend warriors or highly trained athletes to have experienced its severe symptoms ‘first hand.’ But orthopaedic specialists at Thomas Jefferson University Hospital say it's important to be aware of this acute injury before hitting the slopes so you don't end up with chronic pain and dysfunction.

Jefferson Scientists Find Protein Helps Pancreatic Cancer Cells Hide from Immune System, Allowing Spread
(Published 1-10-2008) A protein that helps prevent a woman’s body from rejecting a fetus may also play an important role in enabling pancreatic cancer cells to evade detection by the immune system, allowing them to spread in the body.

Jefferson’s Rural Physicians Program Expands into Delaware
(Published 1-11-2008) The Department of Family and Community Medicine of Jefferson Medical College, Thomas Jefferson University has received a three-year grant from the Bureau of Health Professions (Health Resources and Services Administration, US Department of Health and Human Services) to expand its medical school educational programs. One of the five components of this expansion is to extend Jefferson’s rural Physician Shortage Area Program (PSAP) to the state of Delaware.

Jefferson Specialists Perform High Tech Surgery to Safely Remove up to 75 Percent of Cancerous Livers
(Published 1-15-2008) Transplant surgeons at Thomas Jefferson University Hospital in Philadelphia are using a new method called “bloodless” liver resection to safely remove up to 75 percent of the largest organ in the human body. The technique is improving patients’ odds and cutting recovery time in half.

Jefferson Scientists Uncover Role of Cancer Stem Cell Marker: Controlling Gene Expression Patterns
(Published 1-21-2008) Scientists at Jefferson’s Kimmel Cancer Center in Philadelphia have made an extraordinary advance in the understanding of the function of a gene previously shown to be part of an 11-gene “signature” that can predict which tumors will be aggressive and likely to spread. The gene, USP22, encodes an enzyme that appears to be crucial for controlling large scale changes in gene expression, one of the hallmarks of cancer cells.

Inter-Action: Jefferson Creates New Center for InterProfessional Education
(Published 1-24-2008) Thomas Jefferson University has announced the creation of the Jefferson Center for InterProfessional Education. This new center, one of only a few in the nation, is dedicated to improving patient care through coordination, implementation and evaluation of a team-based education curriculum. This curriculum will include medical, nursing, occupational therapy, physical therapy and pharmacy students, as well as physicians receiving advanced residency and fellowship training at Thomas Jefferson University Hospital.

Jefferson Neurosurgeons Using New Liquid Treatment For Wide-Neck Brain Aneurysm
(Published 1-30-2008) Neurological surgeons at Jefferson Hospital for Neuroscience are among the first surgeons in the United States using an FDA-approved liquid system for treating wide-necked brain aneurysms, which could eventually replace current treatments.